Zhong Guo Jin Rong Xin Xi Wang·2025-08-19 09:23Core Viewpoint - The article discusses the collaborative efforts of various Chinese financial institutions, particularly China Life, to support the innovation and development of the brain-computer interface (BCI) industry, highlighting significant investments and advancements in technology [1][2][5]. Group 1: Policy and Financial Support - The Ministry of Industry and Information Technology and six other departments issued implementation opinions to promote the innovation of the BCI industry [1]. - China Life has actively responded to this policy by integrating financial resources with technological innovation, aiming to accelerate the development of BCI technologies [1][2]. - As of June 2025, China Life's investment in technology self-reliance has exceeded 40 billion yuan, with over 20 projects funded in various advanced fields [2][5]. Group 2: Technological Advancements - A significant breakthrough in BCI was achieved with a clinical trial using high-throughput flexible electrodes developed by Beijing Zhirun Medical Technology Co., which allows for minimal damage during implantation and precise monitoring of neural signals [2][3]. - The BCI technology is being applied in medical, rehabilitation, and nursing fields, enabling patients to perform actions through thought, thus enhancing rehabilitation training [3][4]. Group 3: Investment in Emerging Companies - China Life's dual-carbon fund participated in a recent A-round financing for Zhirun Medical, raising over 300 million yuan to support the development of next-generation invasive flexible BCIs [2]. - Guangfa Bank, a member of China Life Group, provided tailored financial services to Lizi Intelligent Technology, offering a credit intention of 170 million yuan to support its application for national industry funds [4]. - The China Life Health Investment Fund has invested in over 60 projects, focusing on high-tech companies that address critical technological challenges [6].